Pulsed Field Ablation Enables Stromal Manipulation and Tumor Reduction in Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is a particularly stubborn disease, not just because the cells grow quickly, but because of the fortress they build around themselves. In the pancreas, the tumor does not exist in isolation; it is surrounded by a dense, fibrous network of tissue known as the stroma. This material is largely made up of specialized cells called fibroblasts, which act like construction workers, laying down thick layers of scar tissue. While this might sound like a protective barrier, in pancreatic cancer, it actually helps the tumor survive. It blocks drugs from reaching the cancer cells, shields them from the immune system, and sends signals that encourage the tumor to become more aggressive and spread. For decades, scientists have struggled to find a way to break through this wall without harming the patient, often finding that standard treatments either fail to penetrate the tissue or accidentally make the fibrous barrier even stronger.

Researchers at the University of Nebraska Medical Center recently explored a different approach to this problem using a technique called pulsed field ablation. Unlike traditional methods that burn or freeze tissue, this therapy uses short, high-intensity bursts of electricity to punch tiny holes in cell membranes, causing the cells to die without generating heat. The team wanted to see what happens to the tumor and its surrounding fortress when this electricity is applied. They used a mouse model of pancreatic cancer to observe the immediate aftermath and the long-term changes. What they discovered was that the treatment did more than just kill the cancer cells directly; it fundamentally rewired the environment around the tumor, turning the very cells that usually help the cancer grow into cells that help restrain it.

The researchers began by treating tumors that had been growing for 18 days. They applied the electrical pulses to one group of mice while giving a sham treatment to another, where the probe was inserted but no electricity was delivered. Within hours, the treated tumors showed clear signs of damage. The area where the electricity was applied became inflamed, and the cancer cells began to die off rapidly. By 48 hours, the researchers saw a significant increase in the number of dying cells, marked by specific proteins that appear when a cell is in the final stages of death. This area of destruction was filled with neutrophils, a type of white blood cell that acts as the body's first responders to injury, rushing in to clean up the debris. Interestingly, the usual immune cells that hunt down cancer, known as T cells, were not immediately more active in the treated area, suggesting that the initial cleanup was handled by a different part of the immune system.

When the scientists looked at the tumors a week and then eleven days later, they found that the direct killing effect of the electricity had mostly resolved, with the dead tissue being cleared away. However, the tumors that had been treated were still growing much slower than the untreated ones. This suggested that something else was happening beyond the initial destruction. To understand this, the team decided to try a different strategy: instead of one treatment, they gave the mice three rounds of the electrical pulses, spaced three days apart. This repeated approach allowed them to see how the tumor environment changed over time. They found that while the total size of the tumors was similar between those that got one treatment and those that got three, the internal composition was very different. The tumors that received three treatments had significantly more dead tissue and, more importantly, a completely different makeup of living cells.

The most surprising discovery came from analyzing the genetic activity of the cells inside the tumors. The researchers found that the cancer cells themselves had changed their behavior. Instead of acting like aggressive, spreading cells, they shifted toward a state that was more stressed and focused on repairing themselves. But the real transformation happened in the stroma, the fibrous wall surrounding the tumor. In untreated tumors, the fibroblasts were in a highly active, muscle-like state that promoted tumor growth and blocked immune cells. After three rounds of treatment, these cells had changed. They stopped acting like aggressive construction workers and shifted into a different state. These new cells, which the researchers identified by a specific protein marker, began to produce signals that are part of the body's natural defense system, specifically proteins that help tag and clear foreign invaders.

This shift in the fibroblasts appeared to be driven by a chain reaction started by the treatment. The electrical pulses caused cell death, which attracted immune cells that released a specific signaling molecule. This molecule acted like a switch for the fibroblasts, telling them to change their behavior. The new type of fibroblast produced less of a chemical that usually encourages tumors to become more invasive and spread. Consequently, the cancer cells in the treated tumors showed fewer signs of the aggressive changes that allow them to spread to other parts of the body. The treatment effectively turned the tumor's own support system against it, reducing the signals that make the cancer dangerous and increasing the signals that help the body fight back.

The study suggests that pulsed field ablation is not just a tool for destroying tissue, but a way to reprogram the biological environment of a tumor. By using electricity to kill cells in a controlled way, the treatment triggered a sequence of events that led to a less aggressive tumor. The fibroblasts, which usually build the fortress that protects the cancer, were retrained to help dismantle it. While this research was conducted in mice and the results are specific to this model, the findings offer a new perspective on how physical therapies can alter the complex relationships between cancer cells and their surroundings. It points toward a future where treatments might not just aim to kill the tumor, but to change the rules of the game so that the tumor cannot survive in its own environment. The researchers note that further work is needed to see if these changes can be sustained and combined with other therapies to help patients, but the mechanism they uncovered provides a clear path forward for understanding how to make pancreatic cancer more vulnerable.